eBioscience's Debt Round

eBioscience raised a round of funding on February 14, 2011. Investors include GE Capital.

eBioscience provides reagents to researchers worldwide that empower the process of scientific discovery in the areas of cellular immunity and oncology. In June 2012, eBioscience was acquired by Aff…

Articles about eBioscience's Debt Round: